Corona Remedies Ltd press release
Corona Remedies Ltd received Good Manufacturing Practice (GMP) certification from Brazil's ANVISA for its OSD and Women's Hormone facilities at Bhayla, Ahmedabad, on October 22, 2026 (reported earlier).
By ScoutQuest · · 1 min read
- Certification
- Good Manufacturing Practice (GMP) certification from Brazil's ANVISA for its OSD and Women's Hormone facilities
- GMP Accreditations
- third major GMP accreditation, following EU-GMP and EAEU-GMP approvals
- Revenue Geography
- India remains its primary market, contributing over 96% of its revenue
- Release
- Press release
📊 The company said India remains its primary market, contributing over 96% of its revenue.
Also from Corona Remedies
ANVISA GMP certification received for OSD and Hormone facilities at Bhayla, Ahmedabad
22 Oct 2026
Corona Remedies to hold Q2 FY27 earnings conference call on November 02, 2026 at 11:30 a.m. IST
16 Oct 2026
Board meeting on October 30, 2026 to consider unaudited Q2 and half-year results
16 Oct 2026
More numbers
- India share of revenueover 96%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.